2023 annual financial data
Cogent Biosciences 2023 Operating margin
Cogent Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -208,130,000 USD and net income was -192,410,000 USD.
Operating cash flow was -153,624,000 USD.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -208,130,000 USD
- Net income
- -192,410,000 USD
- Operating cash flow
- -153,624,000 USD